Media Newsroom of

Enalare Therapeutics

868 106TH AVE NORTH
Naples, Fl 34108

Enalare Therapeutics Inc. is a clinical stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from acute respiratory conditions.

Native Cardio to Present at the U.S. MedTech Innovator 2021 Road Tour

Native Cardio to Present at the U.S. MedTech Innovator 2021 Road Tour

Native Cardio, Inc. a cardiac medical device manufacturer located in Naples, FL, dedicated to developing medical devices to improve the outcomes of patients suffering from acute and chronic atrial fibrillation, announced today that Joseph Pergolizzi M.D., President and Chief Executive…

Native Cardio to Present at the Georgetown and Maryland PNP University Pitch Session

Native Cardio to Present at the Georgetown and Maryland PNP University Pitch Session

Native Cardio, Inc., a cardiac medical device manufacturer located in Naples, Florida, dedicated to developing medical devices to improve the outcomes of patients suffering from acute and chronic atrial fibrillation, announced today that Joe Pergolizzi, M.D., President and Chief Executive…

Enalare Therapeutics Announces Closing of Successful Seed Funding Round

Enalare Therapeutics Announces Closing of Successful Seed Funding Round

Enalare Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to developing novel therapies for life-threatening acute respiratory and critical care conditions, announced today that it has successfully closed its seed funding round of $10 million. The offering was met with significant…

Enalare Therapeutics Appoints Mark Coleman M.D. to Its Board of Directors

Enalare Therapeutics Appoints Mark Coleman M.D. to Its Board of Directors

Enalare Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to developing novel therapies for patients suffering from acute respiratory conditions, announced today that it has appointed Mark Coleman M.D. to its Board of Directors."We are very excited to have Dr. Coleman join our…

Enalare Therapeutics Appoints Daniel Motto as Chief Business Officer

Enalare Therapeutics Appoints Daniel Motto as Chief Business Officer

Enalare Therapeutics Inc., a biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from acute respiratory conditions, announced today that it has appointed pharmaceutical industry veteran Daniel Motto as its Chief Business Officer. Dan brings more than…

Enalare Therapeutics Appoints Herm Cukier as Executive Chairman, President, and CEO

Enalare Therapeutics Appoints Herm Cukier as Executive Chairman, President, and CEO

Enalare Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from acute respiratory conditions, announced today that it has appointed biopharma industry veteran Herm Cukier as its Executive Chairman of the Board, President, and CEO. ​ Herm brings…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login